Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Outcomes assessment in the NCCN

J C Weeks1

  • 1Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Oncology (Williston Park, N.Y.)
|January 16, 1998
PubMed
Summary

The National Comprehensive Cancer Network (NCCN) is developing a unified system for outcomes assessment. This program aims to evaluate cancer treatments and quality of care by analyzing existing data and establishing benchmarks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers.

Breast cancer research and treatment·2011
Same author

Direct-to-consumer advertising for bleeding disorders: a content analysis and expert evaluation of advertising claims.

Journal of thrombosis and haemostasis : JTH·2008
Same author

Binary data with two, non-nested sources of clustering: an analysis of physician recommendations for early prostate cancer treatment.

Biostatistics (Oxford, England)·2003
Same author

What do patients value in their hospital care? An empirical perspective on autonomy centred bioethics.

Journal of medical ethics·2003
Same author

Cell culture of mechanoreceptor neurons innervating proleg sensory hairs in Manduca sexta larvae, and co-culture with target motoneurons.

Cell and tissue research·2002
Same author

Quality of informed consent in cancer clinical trials: a cross-sectional survey.

Lancet (London, England)·2001

Area of Science:

  • Oncology
  • Health Services Research
  • Biostatistics

Background:

  • Outcomes assessment is crucial for evaluating cancer treatments and quality of care.
  • Existing data can inform clinical guidelines where randomized trials are lacking.
  • Monitoring care patterns and outcomes aids in guideline implementation and benchmarking.

Purpose of the Study:

  • To outline the National Comprehensive Cancer Network's (NCCN) three-phase approach to outcomes assessment.
  • To describe the ongoing efforts in pooling and analyzing existing institutional data.
  • To establish a uniform outcomes assessment system for the NCCN.

Main Methods:

  • Phase 1: Inventory of existing institutional data sources.
  • Phase 2: Pooling data from existing outcomes databases, including the National Cancer Data Base (NCDB) tumor registry.
  • Phase 3: Development of a uniform outcomes assessment system.

Main Results:

  • Phase 1 successfully inventoried data sources.
  • Phase 2 is actively pooling data to examine care patterns and outcomes within NCCN institutions.
  • Benchmarking against national norms is a key component of Phase 2.

Conclusions:

  • The NCCN's phased approach is systematically building a comprehensive outcomes assessment program.
  • Utilizing existing data and establishing benchmarks will enhance cancer care evaluation.
  • A uniform system will standardize outcomes assessment across NCCN institutions.

Related Experiment Videos